New Covid Boosters aren’t Better than Old Ones, Study Finds

Top International News

Bivalent booster shots from Moderna Inc. and Pfizer Inc. failed to raise levels of protective proteins called neutralizing antibodies against the dominant omicron strains any more than four doses of the original Covid vaccine, according to an early independent study on a small group of people.

Credit Bloomberg Quicktake: Now